.After antibody-drug conjugate (ADC) professional Seagen was actually sold to Pfizer last year for a...
.On the heels of a phase 3 succeed that failed to thrill clients, Ironwood Pharmaceuticals is back a...
.Do not quit Monte Rosa Therapeutics now. The Boston-based biotech is enjoying after signing a cope ...
.Welcome to recently's Chutes & Ladders, our summary of substantial management hirings, shootings...
.Celebrating his provider's upsized going public (IPO), Septerna CEO Jeffrey Finer rang the position...
.AbbVie has gone back to the resource of its antipsychotic goliath Vraylar looking for yet another b...
.GenSight Biologics is full weeks out of losing amount of money. Again. The biotech simply has suffi...
.Monopar Therapies is actually bouncing back a drug coming from the dump of AstraZeneca's rare ailme...
.With new records out on Arcus Biosciences' speculative HIF-2a prevention, one team of analysts figu...
.After developing a gene treatment alliance with Dyno Therapeutics in 2020, Roche is back for more.I...